World Vaccine Congress, Europe

Following up WVC in Washington during the spring CSO Anna\-Karin\s+Maltais and CEO Hans\s+Arwidsson will present the latest progress from development of Immunose™\s+FLU, our first vaccine candidate, based on our technology platform Endocine

This conference is about research, development and strategic partnering for the global vaccine industry. Read more here =>

 

Vill du följa Eurocine Vaccines utveckling lättare?

Ta del del av pressreleaser, nyheter och artiklar kring vaccinering och influensa.

Starta din prenumeration här »